Autologous Peripheral Blood Mononuclear Cell Recognition of Autologous Proliferating Tumor Cells in the Context of a Patient-Specific Vaccine Trial

Lignende værker

• Patient-specific dendritic cell vaccines with autologous tumor antigens in 72 patients with metastatic melanoma
  af: Dillman, Robert O, et al.
  Udgivet: (2019)
• Suppression of autologous peripheral blood mononuclear cell proliferation by alveolar macrophages from young infants
  af: BUNN, H J, et al.
  Udgivet: (2002)
• Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses
  af: Robert O. Dillman, et al.
  Udgivet: (2018-03-01)
• Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses
  af: Dillman, Robert O., et al.
  Udgivet: (2018)
• Superiority of dendritic cell vaccine vs tumor cell vaccine: survival by stratification subsets in MACVAC randomized Phase II trial of patient-specific vaccines utilizing antigens from autologous melanoma tumor cell lines
  af: Dillman, Robert O, et al.
  Udgivet: (2015)